Literature DB >> 5773738

Clinical observations on a new antihypertensive drug, 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride.

G Smet, S W Hoobler, S Sanbar, S Julis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5773738     DOI: 10.1016/0002-8703(69)90156-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  7 in total

1.  Clonidine hydrochloride withdrawal complicating bilateral nephrectomy.

Authors:  T P Mate; A H Swerdlin; R A Stone; S M Steinberg
Journal:  West J Med       Date:  1979-07

2.  Antihypertensive effects of lofexidine in patients with essential hypertension.

Authors:  T C Fagan; S S Bloomfield; T D Cowart; R H Corns-Hurwitz; R J Lipicky; E C Conradi; C Y Hsu; W J Grossman; G E Harmon; W J Degenhart; A W Sinkfield; T E Gaffney
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

3.  A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.

Authors:  P R Wilkinson; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

4.  Effects of clonidine withdrawal: possible mechanisms and suggestions for management.

Authors:  S N Hunyor; L Hansson; T S Harrison; S W Hoobler
Journal:  Br Med J       Date:  1973-04-28

5.  Treatment of hypertension with clonidine.

Authors:  A I MacDougall; G J Addis; N MacKay; I W Dymock; A G Turpie; D L Ballingall; W J MacLennan; B Whiting; J G MacArthur
Journal:  Br Med J       Date:  1970-08-22

6.  Crossover comparison of moxonidine and clonidine in mild to moderate hypertension.

Authors:  V Plänitz
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension.

Authors:  A Amery; M Verstraete; H Bossaert; G Verstreken
Journal:  Br Med J       Date:  1970-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.